{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:08:25Z","timestamp":1792390105248,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ejphar.2011.08.053","type":"journal-article","created":{"date-parts":[[2011,9,18]],"date-time":"2011-09-18T01:21:00Z","timestamp":1316308860000},"page":"500-508","source":"Crossref","is-referenced-by-count":33,"title":["The novel small molecule \u03b19\u03b110 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic"],"prefix":"10.1016","volume":"670","author":[{"given":"Joseph R.","family":"Holtman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda P.","family":"Dwoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Dowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta P.","family":"Wala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.08.053_bb0005","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bcp.2007.06.033","article-title":"Neuronal nicotinic receptors: a perspective on two decades of drug discovery research","volume":"74","author":"Arneric","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/aps.2009.47","article-title":"Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors","volume":"30","author":"Azam","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1213\/01.ane.0000268145.52345.55","article-title":"Pain management: a fundamental human right","volume":"105","author":"Brennan","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/mi.4.5.8","article-title":"Neuronal nicotinic receptor subtypes: defining therapeutic targets","volume":"4","author":"Buccafusco","year":"2004","journal-title":"Mol. Interv."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0025","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1523\/JNEUROSCI.3594-08.2008","article-title":"Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation","volume":"28","author":"Callaghan","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0030","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.271.13.7522","article-title":"A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors","volume":"271","author":"Cartier","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)03823-6","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D'Amour","year":"1941","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728220902841045","article-title":"Nicotinic acetylcholine receptors: an overview on drug discovery","volume":"13","author":"D'Hoedt","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0045","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1073\/pnas.051622798","article-title":"Alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells","volume":"98","author":"Elgoyhen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0050","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jmb.2008.01.082","article-title":"Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues","volume":"377","author":"Ellison","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pain.2010.01.007","article-title":"Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain","volume":"149","author":"Gao","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1113\/jphysiol.2005.087155","article-title":"Biophysical and pharmacological characterization of nicotinic cholinergic receptors in rat cochlear inner hair cells","volume":"566","author":"Gomez-Casati","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0065","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jpain.2010.01.138","article-title":"Novel small molecule alpha9alpha10 nicotinic receptor antagonists for pain management","author":"Holtman","year":"2010","journal-title":"Am. Pain Soc. J. Pain"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pbb.2009.09.017","article-title":"The analgesic and toxic effects of nornicotine enantiomers alone and in interaction with morphine in rodent models of acute and persistent pain","volume":"94","author":"Holtman","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pain.2010.09.007","article-title":"A novel mechanism of inhibition of high-voltage activated calcium channels by alpha-conotoxins contributes to relief of nerve injury-induced neuropathic pain","volume":"152","author":"Klimis","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0080","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.toxicon.2006.07.023","article-title":"Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor","volume":"48","author":"Livett","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0085","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/mol.109.056176","article-title":"Selective inhibition of acetylcholine-evoked responses of alpha7 neuronal nicotinic acetylcholine receptors by novel tris- and tetrakis-azaaromatic quaternary ammonium antagonists","volume":"76","author":"Lopez-Hernandez","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0090","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/mol.65.4.944","article-title":"Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors","volume":"65","author":"McIntosh","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bcp.2009.05.020","article-title":"Alpha9 nicotinic acetylcholine receptors and the treatment of pain","volume":"78","author":"McIntosh","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jpain.2008.01.336","article-title":"Activation of the alpha7-nicotinic acetylcholine receptor reverses complete freund adjuvant-induced mechanical hyperalgesia in the rat via a central site of action","volume":"9","author":"Medhurst","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","article-title":"Immune and inflammatory mechanisms in neuropathic pain","volume":"51","author":"Moalem","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0110","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.107.040568","article-title":"Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?","volume":"72","author":"Nevin","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0115","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1432-1033.2004.04145.x","article-title":"Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes","volume":"271","author":"Nicke","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0120","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bja\/aeq113","article-title":"Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain","volume":"105","author":"Rowley","year":"2010","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0130","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1021\/bi034043e","article-title":"A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo","volume":"42","author":"Sandall","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2005.08.009","article-title":"Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones","volume":"1059","author":"Satkunanathan","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0195","series-title":"Manual of pharmacologic calculations with computer programs","author":"Tallarida","year":"1987"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","article-title":"Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system","volume":"8","author":"Taly","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tjolsen","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0150","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1517\/13543784.14.10.1191","article-title":"Neuronal nicotinic receptors as targets for novel analgesics","volume":"14","author":"Vincler","year":"2005","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0155","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1517\/14728222.11.7.891","article-title":"Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain","volume":"11","author":"Vincler","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0160","doi-asserted-by":"crossref","first-page":"17880","DOI":"10.1073\/pnas.0608715103","article-title":"Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors","volume":"103","author":"Vincler","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0165","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/jps.2600531142","article-title":"Semiautomatic system for timing rotarod performance","volume":"53","author":"Watzman","year":"1964","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0170","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0378-5955(02)00380-5","article-title":"The \u03b19\u03b110 nicotinic acetylcholine receptor is permeable to and is modulated by divalent cations","volume":"167","author":"Weisstaub","year":"2002","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02244551","article-title":"Standardization of the rat paw formalin test for the evaluation of analgesics","volume":"104","author":"Wheeler-Aceto","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2011.08.053_bb0180","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.bmcl.2008.09.084","article-title":"Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release","volume":"18","author":"Zhang","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2011.08.053_bb0185","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1016\/j.bmcl.2007.10.062","article-title":"Tris-azaaromatic quaternary ammonium salts: novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release","volume":"17","author":"Zheng","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911009654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911009654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:08:49Z","timestamp":1741705729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911009654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":39,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0014299911009654"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.08.053","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}